Anticancer properties of novel zinc oxide quantum dot nanoparticles against breast cancer stem-like cells
Authors:
- 19 August 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 33 (1) , e311-e326
Abstract
Cancer stem cells (CSCs) play an essential role in cancer development, metastasis, relapse, and resistance to treatment. In this article, the effects of three synthesized ZnO nanofluids on proliferation, apoptosis, and stemness markers of breast cancer stem-like cells are reported. The antiproliferative and apoptotic properties of ZnO nanoparticles were evaluated on breast cancer stem-like cell-enriched mammospheres by MTS assay and flowcytometry, respectively. The expression of stemness markers, including WNT1, NOTCH1, β-catenin, CXCR4, SOX2, and ALDH3A1 was assessed by real-time PCR. Western blotting was used to analyze the phosphorylation of Janus kinase 2 (JAK2) and Signal Transducer and Activator of Transcription 3 (STAT3). Markers of stemness were significantly decreased by ZnO nanofluids, especially sample (c) with code ZnO-148 with a different order of addition of polyethylene glycol solution at the end of formulation, which considerably decreased all the markers compared to the controls. All the studied ZnO nanofluids considerably reduced viability and induced apoptosis of spheroidal and parental cells, with ZnO-148 presenting the most effective activity. Using CD95L as a death ligand and ZB4 as an extrinsic apoptotic pathway blocker, it was revealed that none of the nanoparticles induced apoptosis through the extrinsic pathway. Results also showed a marked inhibition of the JAK/STAT pathway by ZnO nanoparticles; confirmed by downregulation of Mcl-1 and Bcl-XL expression. The present data demonstrated that ZnO nanofluids could combat breast CSCs via decreasing stemness markers, stimulating apoptosis, and suppressing JAK/STAT activity.Keywords
This publication has 49 references indexed in Scilit:
- Assessment of the Evolution of Cancer Treatment TherapiesCancers, 2011
- Breast cancer stem cells: treatment resistance and therapeutic opportunitiesCarcinogenesis, 2011
- Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applicationsExpert Opinion on Drug Delivery, 2010
- Insights into the cell of origin in breast cancer and breast cancer stem cellsAsia-Pacific Journal of Clinical Oncology, 2010
- The cancer stem cell paradigm: a new understanding of tumor development and treatmentExpert Opinion on Therapeutic Targets, 2010
- Preferential killing of cancer cells and activated human T cells using ZnO nanoparticlesNanotechnology, 2008
- Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cellsBreast Cancer Research, 2008
- STAT3 as a target for inducing apoptosis in solid and hematological tumorsCell Research, 2008
- Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?Cell Cycle, 2007
- The Response of CD24 −/low /CD44 + Breast Cancer–Initiating Cells to RadiationJNCI: Journal of the National Cancer Institute, 2006